VERDICT MRI for Prostate Cancer: Intracellular Volume Fraction versus Apparent Diffusion Coefficient

Background Biologic specificity of diffusion MRI in relation to prostate cancer aggressiveness may improve by examining separate components of the diffusion MRI signal. The Vascular, Extracellular, and Restricted Diffusion for Cytometry in Tumors (VERDICT) model estimates three distinct signal components and associates them to (a) intracellular water, (b) water in the extracellular extravascular space, and (c) water in the microvasculature. Purpose To evaluate the repeatability, image quality, and diagnostic utility of intracellular volume fraction (FIC) maps obtained with VERDICT prostate MRI and to compare those maps with apparent diffusion coefficient (ADC) maps for Gleason grade differentiation. Materials and Methods Seventy men (median age, 62.2 years; range, 49.5–82.0 years) suspected of having prostate cancer or undergoing active surveillance were recruited to a prospective study between April 2016 and October 2017. All men underwent multiparametric prostate and VERDICT MRI. Forty-two of the 70 men (median age, 67.7 years; range, 50.0–82.0 years) underwent two VERDICT MRI acquisitions to assess repeatability of FIC measurements obtained with VERDICT MRI. Repeatability was measured with use of intraclass correlation coefficients (ICCs). The image quality of FIC and ADC maps was independently evaluated by two board-certified radiologists. Forty-two men (median age, 64.8 years; range, 49.5–79.6 years) underwent targeted biopsy, which enabled comparison of FIC and ADC metrics in the differentiation between Gleason grades. Results VERDICT MRI FIC demonstrated ICCs of 0.87–0.95. There was no significant difference between image quality of ADC and FIC maps (score, 3.1 vs 3.3, respectively; P = .90). FIC was higher in lesions with a Gleason grade of at least 3+4 compared with benign and/or Gleason grade 3+3 lesions (mean, 0.49 ± 0.17 vs 0.31 ± 0.12, respectively; P = .002). The difference in ADC between these groups did not reach statistical significance (mean, 1.42 vs 1.16 × 10-3 mm2/sec; P = .26). Conclusion Fractional intracellular volume demonstrates high repeatability and image quality and enables better differentiation of a Gleason 4 component cancer from benign and/or Gleason 3+3 histology than apparent diffusion coefficient. Published under a CC BY 4.0 license. Online supplemental material is available for this article. See also the editorial by Sigmund and Rosenkrantz in this issue.

[1]  Hilla Peretz,et al.  Ju n 20 03 Schrödinger ’ s Cat : The rules of engagement , 2003 .

[2]  H. Merisaari,et al.  Evaluation of different mathematical models for diffusion‐weighted imaging of normal prostate and prostate cancer using high b‐values: A repeatability study , 2015, Magnetic resonance in medicine.

[3]  Andriy Fedorov,et al.  Multiparametric Magnetic Resonance Imaging of the Prostate: Repeatability of Volume and Apparent Diffusion Coefficient Quantification , 2017 .

[4]  Stuart A. Taylor,et al.  Imaging biomarker roadmap for cancer studies , 2016, Nature Reviews Clinical Oncology.

[5]  John T. Wei,et al.  Integrative molecular concept modeling of prostate cancer progression , 2007, Nature Genetics.

[6]  Eleftheria Panagiotaki,et al.  Limitations and Prospects for Diffusion-Weighted MRI of the Prostate , 2016, Diagnostics.

[7]  Daniel C. Alexander,et al.  Neurite orientation dispersion and density imaging of the healthy cervical spinal cord in vivo , 2015, NeuroImage.

[8]  David Atkinson,et al.  Optimised VERDICT MRI protocol for prostate cancer characterisation , 2015 .

[9]  L. Turnbull,et al.  Repeatability of echo-planar-based diffusion measurements of the human prostate at 3 T. , 2007, Magnetic resonance imaging.

[10]  Daniel C. Alexander,et al.  Camino: Open-Source Diffusion-MRI Reconstruction and Processing , 2006 .

[11]  Mark McEntee,et al.  Changes in Epithelium, Stroma, and Lumen Space Correlate More Strongly with Gleason Pattern and Are Stronger Predictors of Prostate ADC Changes than Cellularity Metrics. , 2015, Radiology.

[12]  Thomas Hambrock,et al.  Prostate cancer: body-array versus endorectal coil MR imaging at 3 T--comparison of image quality, localization, and staging performance. , 2007, Radiology.

[13]  Janet E Cowan,et al.  Do Adenocarcinomas of the Prostate With Gleason Score (GS)⩽6 Have the Potential to Metastasize to Lymph Nodes? , 2012, The American journal of surgical pathology.

[14]  Misop Han,et al.  Predicting 15-year prostate cancer specific mortality after radical prostatectomy. , 2011, The Journal of urology.

[15]  David Atkinson,et al.  VERDICT‐AMICO: Ultrafast fitting algorithm for non‐invasive prostate microstructure characterization , 2018, NMR in biomedicine.

[16]  B. Delahunt,et al.  The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System , 2015, The American journal of surgical pathology.

[17]  Y. Mazaheri,et al.  Diffusion-Weighted Magnetic Resonance Imaging of the Prostate: Improved Robustness With Stretched Exponential Modeling , 2012, Journal of computer assisted tomography.

[18]  T. Scheenen,et al.  Multiparametric Magnetic Resonance Imaging in Prostate Cancer Management: Current Status and Future Perspectives , 2015, Investigative radiology.

[19]  David Atkinson,et al.  INNOVATE: A prospective cohort study combining serum and urinary biomarkers with novel diffusion-weighted magnetic resonance imaging for the prediction and characterization of prostate cancer , 2016, BMC Cancer.

[20]  D. Nanz,et al.  Comparison of image quality and patient discomfort in prostate MRI: pelvic phased array coil vs. endorectal coil , 2016, Abdominal Radiology.

[21]  Erich P Huang,et al.  Metrology Standards for Quantitative Imaging Biomarkers. , 2015, Radiology.

[22]  D. Hawkes,et al.  Microstructural Characterization of Normal and Malignant Human Prostate Tissue With Vascular, Extracellular, and Restricted Diffusion for Cytometry in Tumours Magnetic Resonance Imaging , 2015, Investigative radiology.